Similar articles

• Antiretroviral therapy for HIV-2 infected patients.

  Smith NA, Shaw T, Berry N, Vella C, Okorafor L, Taylor D, Ainsworth J, Choudhury A, Daniels RS, El-Gadi S, Fakoya A, Moyle G, Oxford J, Tedder R, O'Shea S, de Ruiter A, Breuer J. Smith NA, et al. J Infect. 2001 Feb;42(2):126-33. doi: 10.1053/jinf.2001.0792. J Infect. 2001. PMID: 11531319
• An investigation of the possible interaction between the use of Vitamin C and highly active antiretroviral therapy (HAART) adherence and effectiveness in treated HIV+ women.

  Merenstein D, Wang C, Gandhi M, Robison E, Levine AM, Schwartz RM, Weber KM, Liu C. Merenstein D, et al. Complement Ther Med. 2012 Aug;20(4):222-7. doi: 10.1016/j.ctim.2012.03.001. Epub 2012 Apr 8. Complement Ther Med. 2012. PMID: 22579434 Free PMC article.
• British HIV Association guidelines for antiretroviral treatment of HIV Seropositive individuals.

  Harindra V. Harindra V. Lancet. 1997 Jun 21;349(9068):1838. doi: 10.1016/S0140-6736(05)61720-5. Lancet. 1997. PMID: 9269233 No abstract available.
• British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals.

  Carey PB, Lloyd J, Timmins D. Carey PB, et al. Lancet. 1997 Jun 21;349(9068):1837. doi: 10.1016/s0140-6736(05)61718-7. Lancet. 1997. PMID: 9269231 No abstract available.
• Sorting through confusing messages: the art of HAART.

  Powderly WG. Powderly WG. J Acquir Immune Defic Syndr. 2002 Sep 1;31 Suppl 1:S3-9; discussion S24-5. doi: 10.1097/00126334-200209011-00002. J Acquir Immune Defic Syndr. 2002. PMID: 12218438 Review. No abstract available.